HOME    Pharmaceuticals    Captopril Tablets

Captopril Tablets

Angiotensin converting enzyme inhibitor
  • Specification
  • Oral Dosage
  • Dosage Forms
  • Packing Materials
    ALU/PVC Blister;Bottles
  • Packaging
  • Active Ingredients:


    Hypertension: The management of mild to moderate hypertension. In severe hypertension it should be used where standard therapy is ineffective or inappropriate.

    Congestive heart failure: Captopril is indicated for the treatment of congestive heart failure. The drug should be used together with diuretics and, when appropriate, digitalis and beta-blockers.

    In patients on doses of over 100 mg daily plus or minus a diuretic, in those with severe renal impairment or those with severe congestive heart failure use of captopril should be under specialist supervision.

    Myocardial Infarction:
    - short-term (4 weeks) treatment: Captopril is indicated in any clinically stable patient within the first 24 hours of an infarction.
    - long-term prevention of symptomatic heart failure: Captopril is indicated in clinically stable patients with asymptomatic left ventricular dysfunction (ejection fraction ≤ 40%) following myocardial infarction to improve survival, delay the onset of symptomatic heart failure, reduce hospitalisations for heart failure and reduce recurrent myocardial infarction and coronary revascularisation procedures.
    Before starting therapy, cardiac function should be determined by radionuclide ventriculography or echocardiography.

    Type I Diabetic nephropathy: Captopril is indicated in insulin dependent diabetics for the treatment of macroproteinuric diabetic nephropathy (microalbuminuria greater than 30 mg/day) (see section 5.1). Captopril may prevent the progression of the renal disease and reduce associated clinical events e.g. dialysis, renal transplantation and death.

    Captopril can be used alone or in combination with other antihypertensive agents.


    Store in an airtight container, protect from light. 

Product Specifications